Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: therapeutic implications. (Q38154840)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24150993%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: therapeutic implications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24150993%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24150993%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

George Anderson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24150993%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Steven Moylan

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24150993%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

3

Olivia Dean

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24150993%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Michael Maes

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24150993%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

1 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24150993%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24150993%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24150993%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24150993%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

1-10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24150993%20AND%20SRC:MED&resulttype=core&format=json

New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

28 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Biological underpinnings of the commonalities in depression, somatization, and Chronic Fatigue Syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Biological significance of soluble IL-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Increased serum soluble CD8 or suppressor/cytotoxic antigen concentrations in depression: suppressive effects of glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Indicators of immune activation in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Emerging tendency towards autoimmune process in major depressive patients: a novel insight from Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Regionally-specific changes in levels of tumour necrosis factor in the dorsolateral prefrontal cortex obtained postmortem from subjects with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Possible association between -G308A tumour necrosis factor-alpha gene polymorphism and major depressive disorder in the Korean population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Monocyte chemoattractant protein-1 (MCP1) promoter -2518 polymorphism may confer a susceptibility to major depressive disorder in the Korean population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

A review on the acute phase response in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Convergent effects of acute stress and glucocorticoid exposure upon MAO-A in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Cytokines mediated inflammation and decreased neurogenesis in animal models of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Do symptoms of depression predict telomere length? Evidence from the west of Scotland twenty-07 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Oxidative stress in university students during examinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

The relevance of oxidative stress status in first episode and recurrent depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Age-associated changes in oxidative stress and NAD+ metabolism in human tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

4-hydroxynonenal as a bioactive marker of pathophysiological processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: New pathways that underpin the inflammatory and neuroprogressive pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Immunogenicity of an inflammation-associated product, tyrosine nitrated self-proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Low plasma vitamin E levels in major depression: diet or disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Antioxidative enzymes and increased oxidative stress in depressive women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Morning and nocturnal serum melatonin rhythm levels in patients with major depressive disorder: an analytical cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Dietary selenium and major depression: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Total antioxidant capacity and total oxidant status in patients with major depression: impact of antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Nrf2 activation by sulforaphane restores the age-related decrease of T(H)1 immunity: role of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Mitochondrial involvement in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Glutathione: a novel treatment target in psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

SIRT1 gene is associated with major depressive disorder in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

4-Hydroxynonenal inhibits SIRT3 via thiol-specific modification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

The role of zinc in neurodegenerative inflammatory pathways in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: Markers that further explain the higher incidence of neurodegeneration and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Increased autoimmune activity against 5-HT: a key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Molecular hydrogen: an overview of its neurobiological effects and therapeutic potential for bipolar disorder and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

The circadian clock circuitry and the AHR signaling pathway in physiology and pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Neuroprogression: pathways to progressive brain changes in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: implications for the pathways to chronic depression and neuroprogression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Treatment response for acute depression is not associated with number of previous episodes: lack of evidence for a clinical staging model for major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Effect of melatonin cotreatment against kainic acid on coenzyme Q10, lipid peroxidation and Trx mRNA in rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Apolipoprotein E influences melatonin biosynthesis by regulating NAT and MAOA expression in C6 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Pineal melatonin and the innate immune response: the TNF-alpha increase after cesarean section suppresses nocturnal melatonin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress--preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Single nucleotide polymorphisms and mRNA expression for melatonin MT(2) receptor in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Activation of cell-mediated immunity in depression: Association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

The inflammatory response following delivery is amplified in women who previously suffered from major depression, suggesting that major depression is accompanied by a sensitization of the inflammatory response system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Interferon-gamma increases neuronal death in response to amyloid-beta1-42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Infliximab improves quality of life in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

The chemistry and biological activities of N-acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Synergist effects of n-acetylcysteine and deferoxamine treatment on behavioral and oxidative parameters induced by chronic mild stress in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Immobilization stress induces cell death through production of reactive oxygen species in the mouse cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Antidepressant-like effect of the organoselenium compound ebselen in mice: evidence for the involvement of the monoaminergic system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

The association between fruit and vegetable consumption and mental health disorders: evidence from five waves of a national survey of Canadians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Fruit, vegetable, and antioxidant intakes are lower in older adults with depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Does minocycline have antidepressant effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Antidepressant-like actions of minocycline combined with several glutamate antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Targeting cyclooxygenase-2 in depression is not a viable therapeutic approach and may even aggravate the pathophysiology underpinning depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

PPARγ agonist pioglitazone inhibits microglia inflammation by blocking p38 mitogen-activated protein kinase signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Multiple sclerosis, seizures, and antiepileptics: role of IL-18, IDO, and melatonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

The inflammasome: pathways linking psychological stress, depression, and systemic illnesses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Epigenetic targets for melatonin: induction of histone H3 hyperacetylation and gene expression in C17.2 neural stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Glutamine: role in gut protection in critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Gut-brain axis: how the microbiome influences anxiety and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Dietary Omega-3 Fatty Acids and Depression in a Community Sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Antidepressant efficacy of agomelatine versus SSRI/SNRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Acute phase proteins in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0119-1

Antidepressants versus placebo for depression in primary care

21 January 2018

1 reference

12 December 2020

A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids

1 reference

12 December 2020

The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression

1 reference

12 December 2020

Immune disturbances during major depression: upregulated expression of interleukin-2 receptors

1 reference

12 December 2020

Association Study of the Interleukin-1beta (C-511T) Genetic Polymorphism with Major Depressive Disorder, Associated Symptomatology, and Antidepressant Response

1 reference

12 December 2020

TRYCAT pathways link peripheral inflammation, nicotine, somatization and depression in the etiology and course of Parkinson's disease.

1 reference

12 December 2020

Omega-3 fatty acids have antidepressant activity in forced swimming test in Wistar rats

1 reference

12 December 2020

Inflammasome signaling at the heart of central nervous system pathology

1 reference

12 December 2020

The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters

1 reference

12 December 2020

Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways.

1 reference

12 December 2020

The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive disorder

1 reference

12 December 2020

Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness

1 reference

12 December 2020

Interleukin-12 and interleukin-18 induce indoleamine 2,3-dioxygenase (IDO) activity in human osteosarcoma cell lines independently from interferon-gamma

1 reference

12 December 2020

Kynurenine pathway enzymes in brain: responses to ischemic brain injury versus systemic immune activation

1 reference

12 December 2020

Lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis / chronic fatigue syndrome: another pathway that may be associated with coronary artery disease and neuroprogression in depression.

1 reference

12 December 2020

Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?

1 reference

12 December 2020

Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis / chronic fatigue syndrome.

1 reference

12 December 2020

Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls

1 reference

12 December 2020

Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients

1 reference

12 December 2020